Anixa Non Current Assets Total from 2010 to 2024

ANIX Stock  USD 3.10  0.05  1.64%   
Anixa Biosciences Non Current Assets Total yearly trend continues to be fairly stable with very little volatility. Non Current Assets Total will likely drop to about 181.4 K in 2024. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
1985-10-31
Previous Quarter
166 K
Current Value
153 K
Quarterly Volatility
3.3 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa main balance sheet or income statement drivers, such as Interest Expense of 217 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many exotic indicators such as Price To Sales Ratio of 861, Dividend Yield of 7.0E-4 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
This module can also supplement Anixa Biosciences' financial leverage analysis and stock options assessment as well as various Anixa Biosciences Technical models . Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Anixa Biosciences over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Anixa Biosciences' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Anixa Non Current Assets Total Regression Statistics

Arithmetic Mean1,376,214
Geometric Mean619,576
Coefficient Of Variation114.11
Mean Deviation1,318,219
Median300,000
Standard Deviation1,570,435
Sample Variance2.5T
Range4.7M
R-Value(0.72)
Mean Square Error1.3T
R-Squared0.52
Significance0
Slope(253,014)
Total Sum of Squares34.5T

Anixa Non Current Assets Total History

2024181.4 K
2023190.9 K
2022166 K
2021212 K
2020254 K
201984.3 K
2018200.6 K

About Anixa Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Anixa Biosciences income statement, its balance sheet, and the statement of cash flows. Anixa Biosciences investors use historical funamental indicators, such as Anixa Biosciences's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Anixa Biosciences investors may use each financial statement separately, they are all related. The changes in Anixa Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Anixa Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Anixa Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Assets Total190.9 K181.4 K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Anixa Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Anixa Biosciences' short interest history, or implied volatility extrapolated from Anixa Biosciences options trading.

Pair Trading with Anixa Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anixa Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Anixa Stock

  0.81IOVA Iovance Biotherapeutics Financial Report 14th of May 2024 PairCorr
  0.78NUVB Nuvation Bio Financial Report 2nd of May 2024 PairCorr
  0.7JSPRW Jasper TherapeuticsPairCorr
  0.67ZNTL Zentalis PharmaceuticalsL Financial Report 8th of May 2024 PairCorr
  0.66MRSN Mersana Therapeutics Downward RallyPairCorr
The ability to find closely correlated positions to Anixa Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anixa Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anixa Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anixa Biosciences to buy it.
The correlation of Anixa Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anixa Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anixa Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anixa Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Anixa Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anixa Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anixa Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anixa Biosciences Stock:
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Anixa Stock analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Anixa Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.34)
Revenue Per Share
0.007
Return On Assets
(0.28)
Return On Equity
(0.43)
The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.